Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-01 4:54 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | BlackRock Inc. BLK | 1,863,142 6.2% | 477,907 (+34.50%) | View |
| 2022-12-20 3:50 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | KOTLER KEVIN | 1,899,930 6.3% | 1,899,930 (New Position) | View |
| 2022-10-21 4:01 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,481,000 8.25% | 2,481,000 (New Position) | View |
| 2022-10-17 4:08 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | CITADEL ADVISORS LLC | 1,334,873 4.4% | 1,334,873 (New Position) | View |
| 2022-10-14 9:10 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management, L.P. | 2,102,037 7.3% | 2,102,037 (New Position) | View |
| 2022-09-23 4:31 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | PERCEPTIVE ADVISORS LLC | 2,099,952 7% | 2,099,952 (New Position) | View |
| 2022-02-14 4:19 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II, L.P. | 2,270,072 8.2% | 1,601,632 (+239.61%) | View |
| 2022-02-14 08:43 am Purchase | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 2,186,324 7.9% | 673,651 (+44.53%) | View |
| 2022-02-11 10:08 am Sale | 13G | Relmada Therapeutics, Inc. RLMD | Avoro Capital Advisors LLC | 0 0% | -1,525,000 (Position Closed) | View |
| 2022-02-03 4:41 pm Sale | 13G | Relmada Therapeutics, Inc. RLMD | BlackRock Inc. BLK | 1,385,235 5.2% | -107,784 (-7.22%) | View |
| 2021-12-20 4:51 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | BIOTECHNOLOGY VALUE FUND L P | 1,647,400 5.9% | 1,647,400 (New Position) | View |
| 2021-12-20 4:33 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 2,000,000 7.2% | 2,000,000 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0% | -761,666 (Position Closed) | View |
| 2021-02-16 4:15 pm Sale | 13G | Relmada Therapeutics, Inc. RLMD | TANG CAPITAL PARTNERS LP | 200,000 1.2% | -1,100,000 (-84.62%) | View |
| 2021-02-16 4:10 pm Sale | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II, L.P. | 668,440 4.1% | -214,374 (-24.28%) | View |
| 2021-02-12 09:38 am Purchase | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 1,512,673 9.31% | 256,816 (+20.45%) | View |
| 2021-02-12 08:05 am Purchase | 13G | Relmada Therapeutics, Inc. RLMD | Avoro Capital Advisors LLC | 1,525,000 9.4% | 1,525,000 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | BlackRock Inc. BLK | 1,493,019 9.2% | 1,493,019 (New Position) | View |
| 2020-06-11 08:54 am Purchase | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 1,255,857 8.26% | 1,255,857 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 761,666 5.4% | 761,666 (New Position) | View |